Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation
Open Access
- 24 October 2017
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 22 (2) , 1138-1147
Abstract
Bone destructive diseases are common worldwide and are caused by dysregulation of osteoclast formation and activation. During osteoclastogenesis, reactive oxygen species (ROS) play a role in the intracellular signalling triggered by receptor activator of nuclear factor‐κB ligand (RANKL) stimulation. Previously, we demonstrated that induction of antioxidant enzymes by Nrf2 activation using Nrf2‐gene transfer, an ETGE‐peptide or polyphenols, successfully ameliorated RANKL‐dependent osteoclastogenesis. Dimethyl fumarate (DMF) has been shown to activate Nrf2 signalling and has been lately used in clinical trials for neurodegenerative diseases. In this study, we hypothesized that Nrf2 activation by DMF would inhibit osteoclastogenesis and bone destruction via attenuation of intracellular ROS signalling through antioxidant mechanisms. RAW 264.7 cells were used as osteoclast progenitor cells. We found that DMF induced Nrf2 translocation to the nucleus, augmented Nrf2 promoter‐luciferase reporter activity and increased antioxidant enzyme expression. Using flow cytometry, we found that DMF attenuated RANKL‐mediated intracellular ROS generation, which resulted in the inhibition of RANKL‐mediated osteoclastogenesis. Local DMF injection into the calvaria of male BALB/c mice resulted in attenuated bone destruction in lipopolysaccharide‐treated mice. In conclusion, we demonstrated in a preclinical setting that DMF inhibited RANKL‐mediated osteoclastogenesis and bone destruction via induction of Nrf2‐mediated transcription of antioxidant genes and consequent decrease in intracellular ROS levels. Our results suggest that DMF may be a promising inhibitor of bone destruction in diseases like periodontitis, rheumatoid arthritis and osteoporosis.Keywords
Funding Information
- Japan Society for the Promotion of Science (23689081, 25670841, 15K11356, 16H05552, 16K11797, 15K11376)
This publication has 48 references indexed in Scilit:
- The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species SignalingJournal of Biological Chemistry, 2013
- Hesperetin Alleviates the Inhibitory Effects of High Glucose on the Osteoblastic Differentiation of Periodontal Ligament Stem CellsPLOS ONE, 2013
- Validation of the multiple sensor mechanism of the Keap1-Nrf2 systemFree Radical Biology and Medicine, 2012
- Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 PathwayThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Dimethyl Fumarate, an Immune Modulator and Inducer of the Antioxidant Response, Suppresses HIV Replication and Macrophage-Mediated Neurotoxicity: A Novel Candidate for HIV NeuroprotectionThe Journal of Immunology, 2011
- Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTORPLOS ONE, 2011
- Development of oral immunomodulatory agents in the management of multiple sclerosisDrug Design, Development and Therapy, 2011
- Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting β-Catenin from T Cell Factor- to Forkhead Box O-mediated TranscriptionJournal of Biological Chemistry, 2007
- Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltrationClinical and Experimental Immunology, 2006
- Stimulation of osteoclastic bone resorption by hydrogen peroxideBiochemical and Biophysical Research Communications, 1992